The Release Rate of Indomethacin from Solid Dispersions with Eudragite
- 1 January 1991
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 17 (14), 2017-2028
- https://doi.org/10.3109/03639049109048065
Abstract
The coprecipitates were prepared by a solvent technique using Eudragit E as carrier and indomethacin as a model drug. X-Ray diffractometry, differential scanning calorimetry (DSC) and wettability tests were employed to investigate the physical state of the studied formulations. Up to 50% of indomethacin can be dispersed in an amorphous state in Eudragit E. The influence of the pH on the in vitro release of solid dispersions has been evaluated. Because of the good solubility of Eudragit E at pH 1.2 a fast dissolution rate of the drug was observed while a marked delay was noticed at pH 7.5 where the polymer is only permeable to water. At pH 5.8 the kinetics of drug release can be modulated by the drug/polymer ratio. The dissolution rate of the drug can be increased by decreasing its amount in the coevaporate.Keywords
This publication has 5 references indexed in Scilit:
- Sustained release solid dispersions of indomethacin with Eudragit RS and RLInternational Journal of Pharmaceutics, 1989
- Enhanced dissolution rate of aspirin from aspirin-methacrylic acid, methyl methacrylate coacervates in a simulated intestinal fluidInternational Journal of Pharmaceutics, 1988
- Physical properties of solid dispersions of poorly water-soluble drugs with enteric coating agents.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985
- IndomethacinAnalytical Profiles of Drug Substances, 1984
- A New Approach for Controlling the Release Rate of Pheniramine Aminosalicylate Via Solid Dispersion in Different Types of EudragitDrug Development and Industrial Pharmacy, 1984